Selling The Skinny
With the threats from compounders and generics mostly contained, we can take a look at the latest piece of GLP-1 news.
With the threats from compounders and generics mostly contained, we can take a look at the latest piece of GLP-1 news.
For those hoping for a quick answer to whether generics will be able to enter the market, it looks like it will take a Federal Circuit decision, probably by the end of 2026 at the earliest.
How do you keep up with the competition? Share your perspective in this brief survey to help us benchmark your lifelong training in professional skills. As a thank you, qualified respondents receive a chance to win a $250 gift card.